Enoximone
Clinical data | |
---|---|
Routes of administration | Intravenous |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 50% (oral) |
Protein binding | 85% |
Metabolism | Hepatic oxidation |
Elimination half-life | 4 to 10 hours |
Excretion | Renal (60 to 70%) |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C12H12N2O2S |
Molar mass | 248.302 g/mol |
3D model (JSmol) | |
|
WikiDoc Resources for Enoximone |
Articles |
---|
Most recent articles on Enoximone |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Enoximone at Clinical Trials.gov Clinical Trials on Enoximone at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Enoximone
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Enoximone Discussion groups on Enoximone Directions to Hospitals Treating Enoximone Risk calculators and risk factors for Enoximone
|
Healthcare Provider Resources |
Causes & Risk Factors for Enoximone |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Enoximone (INN, trade name Perfan) is an imidazole phosphodiesterase inhibitor. It is used in the treatment of congestive heart failure.[1]
References
- ↑ Boldt J, Suttner S (September 2007). "Combined use of ultra-short acting beta-blocker esmolol and intravenous phosphodiesterase 3 inhibitor enoximone". Expert Opin Pharmacother. 8 (13): 2135–47. doi:10.1517/14656566.8.13.2135. PMID 17714066.
Template:Phosphodiesterase inhibitors Template:Cardiac stimulants excluding cardiac glycosides
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- Cardiovascular Drugs
- Drug
- Phosphodiesterase inhibitors
- Inotropic agents
- Vasodilators